International Aids Vaccine Initiative Inc.
New York, NY
- UEI
- ZEJBC8JQM3P5
- CAGE
- 44YM6
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Nairobi, Nairobi County PQ84Z4K6YV79
-
- SAM.gov registration date
- Physical address
- 125 Broad St Fl 9, New York, NY 10004, USA
- Website
- iavi.org
- Founded
- 1996
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health & Wellness
- SIC code
- 83 Social Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $630,717 |
| FY2025 | $3,172,944 |
| FY2024 | $4,890,671 |
| FY2023 | $55,560,136 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $630,717 |
Contract vehicles
Expired vehicles (1)
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Scripps Research Institute | UM1AI144462 | $83,808 | |
| Scripps Research Institute | UM1AI144462 | $749,658 | |
| Scripps Research Institute | UM1AI144462 | $1,295,227 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | U01AI152969 | $60,000 | |
| Scripps Research Institute | UM1AI144462 | $45,789 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| HIV Research And Health Systems Strengthening | Entebbe, Central Region | — |
| Statens Serum Institut | København | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Translational Health Science And Technology Institute | Pali, HR | — |
| Tendel Therapies Inc. | Kensington, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Neovaxsyn Inc. | Ames, IA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI provides a range of research, development, manufacturing, and advocacy services to advance the creation and delivery of vaccines and antibodies to prevent infectious diseases worldwide.
Through prime and subcontract awards from federal agencies like the National Institutes of Health (NIH), IAVI has provided preclinical and analytical services to support vaccine development for HIV, tuberculosis, influenza, Ebola, and other infectious diseases. Services include process development, analytical testing, manufacturing, toxicology studies, regulatory support, and clinical trial material production. IAVI serves as the prime contractor on many awards, partnering with subcontractors like universities, biotechnology companies, and research institutes to provide specialized expertise. The majority of IAVI's contract work has been funded by NIH institutes like NIAID and NCI, as well as BARDA, to advance promising vaccine candidates through preclinical and clinical testing. Most awards have not had set-aside designations.
Through prime and subawards from federal grant programs at agencies like NIH and USAID, IAVI has conducted research to develop novel HIV and tuberculosis vaccine candidates using cutting-edge platforms like mRNA. Additionally, IAVI has been funded to organize scientific conferences, provide technical assistance and business guidance to product developers, conduct health economics evaluations, and support advocacy efforts around HIV prevention research and domestic resource mobilization. As a subawardee, IAVI has contributed expertise in immunology, manufacturing, regulatory affairs, and clinical trial planning to multi-institution research consortia overseen by prime grantee organizations.
IAVI holds multiple indefinite delivery/indefinite quantity (IDIQ) contracts with NIH, including vehicles with NIAID for preclinical services supporting biopharmaceutical product development and preclinical/translational vaccine development for HIV and other infectious diseases. Under these IDIQs, IAVI provides a comprehensive suite of services across all stages of the product development lifecycle through multi-year task order awards. Services include product development planning, analytical testing, process and assay development, cGMP manufacturing, regulatory support, and storage/logistics. Federal agencies can issue task orders against these IDIQs to advance promising vaccines, therapeutics, and diagnostics towards clinical trials and licensure.
Quick answers
Is International Aids Vaccine Initiative Inc. registered in SAM.gov?
Yes. International Aids Vaccine Initiative Inc.'s SAM.gov registration is active through November 4, 2026.
Which contract vehicles does International Aids Vaccine Initiative Inc. hold?
International Aids Vaccine Initiative Inc. holds a place on 2 federal contract vehicles, including Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
How much has International Aids Vaccine Initiative Inc. received in federal contracts?
Federal contracts obligated $3,172,944 to International Aids Vaccine Initiative Inc. in fiscal year 2025 and $64,254,468 in fiscal years 2023 through 2027.
How does International Aids Vaccine Initiative Inc. rank among federal contractors?
International Aids Vaccine Initiative Inc. ranked #52 in PSC AN12 in FY2025.
What is International Aids Vaccine Initiative Inc.'s most recent federal award?
International Aids Vaccine Initiative Inc.'s most recent federal contract award is Contract HHSN272201800010I international aids vaccine initiative manufacture of influenza virus human challenge… (75N93023F00001), from National Institute of Allergy and Infectious Diseases (NIH), on September 26, 2023.
On GovTribe
See International Aids Vaccine Initiative Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors